Masahito Tsurusawa Selected Research

Masahito Tsurusawa Research Topics

Disease

13	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 08/2018 - 05/2002
10	Leukemia 10/2016 - 05/2002
6	Lymphoma (Lymphomas) 01/2018 - 01/2015
5	Neoplasms (Cancer) 01/2014 - 05/2002
3	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 02/2018 - 10/2005
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2016 - 08/2008
3	Residual Neoplasm 12/2010 - 05/2002
2	Infections 07/2011 - 02/2010
2	Disease Progression 05/2009 - 08/2008
1	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2018
1	Virus Diseases (Viral Diseases) 10/2016
1	Central Nervous System Diseases (CNS Diseases) 03/2016
1	Philadelphia Chromosome 05/2015
1	Osteonecrosis (Kienbock's Disease) 01/2014
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2011
1	Cardiotoxicity 09/2011
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 08/2011
1	Down Syndrome (Down's Syndrome) 07/2011
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 07/2011
1	Hyperuricemia 11/2009
1	Hematologic Neoplasms (Hematological Malignancy) 11/2009
1	Tumor Lysis Syndrome 11/2009
1	Hypersensitivity (Allergy) 11/2009
1	Pruritus (Itching) 11/2009
1	Respiratory Insufficiency (Respiratory Failure) 08/2008
1	B-Cell Leukemia (Leukemia, B Cell) 08/2008
1	Pulmonary Alveolar Proteinosis 08/2008
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 02/2007
1	Wilms Tumor (Wilm's Tumor) 03/2006
1	Rhabdomyosarcoma 03/2006
1	Leiomyosarcoma 03/2006
1	Sarcoma (Soft Tissue Sarcoma) 03/2006
1	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 08/2005
1	Nephrotic Syndrome (Syndrome, Nephrotic) 06/2003

Drug/Important Bio-Agent (IBA)

2	Imatinib Mesylate (Gleevec)FDA Link 05/2015 - 10/2011
2	Methotrexate (Mexate)FDA LinkGeneric 01/2015 - 01/2014
2	Cytarabine (Cytosar-U)FDA LinkGeneric 07/2011 - 02/2010
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2009 - 05/2002
1	Anaplastic Lymphoma KinaseIBA 02/2018
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2018
1	Rituximab (Mabthera)FDA Link 10/2016
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2016
1	SteroidsIBA 01/2014
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2014
1	pirarubicinIBA 09/2011
1	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2011
1	AntigensIBA 08/2011
1	CD7 AntigensIBA 08/2011
1	rasburicase (Elitek)FDA Link 11/2009
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 08/2008
1	Pharmaceutical PreparationsIBA 03/2006
1	Irinotecan (Camptosar)FDA LinkGeneric 03/2006
1	Tumor Biomarkers (Tumor Markers)IBA 03/2006
1	Vinblastine (Vinblastine Sulfate)FDA Link 10/2005
1	Antineoplastic Agents (Antineoplastics)IBA 10/2005
1	Intravenous Immunoglobulins (IVIG)FDA Link 08/2005
1	Asparaginase (Elspar)FDA Link 03/2004
1	AsparagineIBA 03/2004
1	Prednisolone (Predate)FDA LinkGeneric 06/2003
1	Immunoglobulins (Immunoglobulin)IBA 05/2002
1	gamma-delta T-Cell Antigen Receptors (T-Cell Receptor delta-Chain)IBA 05/2002

Therapy/Procedure

12	Therapeutics 08/2018 - 02/2005
6	Drug Therapy (Chemotherapy) 01/2015 - 05/2002
2	Remission Induction 07/2011 - 02/2010
2	Hematopoietic Stem Cell Transplantation 05/2009 - 08/2008
1	Salvage Therapy 10/2016
1	Radiotherapy 03/2016
1	Stem Cell Transplantation 05/2015
1	Spinal Injections 01/2014
1	Respiratory Therapy (Therapy, Respiratory) 08/2008